Pan-cancer analysis supports MAPK12 as a potential prognostic and immunotherapeutic target in multiple tumor types, including in THCA
Abstract P38 mitogen-activated protein kinase (MAPK)12 (also known as P38 γ) is critical in the development and progression of various…
